Cargando…
Botulinum a toxin treatment of hemifacial spasm and blepharospasm.
We studied the effects of botulinum A toxin in 101 patients with hemifacial spasm and 11 patients with blepharospasm in an open trial and double blind manner. All patients in the open trial and 6 patients in the double blind trial improved after the first injection of botulinum toxin. There was no i...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Academy of Medical Sciences
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053713/ https://www.ncbi.nlm.nih.gov/pubmed/8305141 |
_version_ | 1782199792333488128 |
---|---|
author | Park, Y. C. Lim, J. K. Lee, D. K. Yi, S. D. |
author_facet | Park, Y. C. Lim, J. K. Lee, D. K. Yi, S. D. |
author_sort | Park, Y. C. |
collection | PubMed |
description | We studied the effects of botulinum A toxin in 101 patients with hemifacial spasm and 11 patients with blepharospasm in an open trial and double blind manner. All patients in the open trial and 6 patients in the double blind trial improved after the first injection of botulinum toxin. There was no improvement with placebo. The peak effect ranged from one to 6 days after injection and mean peak effect was 3.6 days in blepharospasm, and 4 days in hemifacial spasm. Of 144 treatments, 98.6% had excellent results, (below grade I). The duration of beneficial effect ranged 11 to 40 weeks (mean 16.5 weeks) in hemifacial spasm and 9 to 30 weeks (mean 14.2 weeks) in blepharospasm. Complications were encountered in 63.4% in hemifacial spasm and 72.7% in blepharospasm. The common side effects were dry eyes, mouth droop, ptosis and lid edema in order of frequency. These side effects were mild and resolved spontaneously in 1 to 3 weeks. Botulinum A toxin therapy is effective and convenient, and the treatment of choice for patients with hemifacial spasm and blepharospasm. |
format | Text |
id | pubmed-3053713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1993 |
publisher | Korean Academy of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-30537132011-03-16 Botulinum a toxin treatment of hemifacial spasm and blepharospasm. Park, Y. C. Lim, J. K. Lee, D. K. Yi, S. D. J Korean Med Sci Research Article We studied the effects of botulinum A toxin in 101 patients with hemifacial spasm and 11 patients with blepharospasm in an open trial and double blind manner. All patients in the open trial and 6 patients in the double blind trial improved after the first injection of botulinum toxin. There was no improvement with placebo. The peak effect ranged from one to 6 days after injection and mean peak effect was 3.6 days in blepharospasm, and 4 days in hemifacial spasm. Of 144 treatments, 98.6% had excellent results, (below grade I). The duration of beneficial effect ranged 11 to 40 weeks (mean 16.5 weeks) in hemifacial spasm and 9 to 30 weeks (mean 14.2 weeks) in blepharospasm. Complications were encountered in 63.4% in hemifacial spasm and 72.7% in blepharospasm. The common side effects were dry eyes, mouth droop, ptosis and lid edema in order of frequency. These side effects were mild and resolved spontaneously in 1 to 3 weeks. Botulinum A toxin therapy is effective and convenient, and the treatment of choice for patients with hemifacial spasm and blepharospasm. Korean Academy of Medical Sciences 1993-10 /pmc/articles/PMC3053713/ /pubmed/8305141 Text en |
spellingShingle | Research Article Park, Y. C. Lim, J. K. Lee, D. K. Yi, S. D. Botulinum a toxin treatment of hemifacial spasm and blepharospasm. |
title | Botulinum a toxin treatment of hemifacial spasm and blepharospasm. |
title_full | Botulinum a toxin treatment of hemifacial spasm and blepharospasm. |
title_fullStr | Botulinum a toxin treatment of hemifacial spasm and blepharospasm. |
title_full_unstemmed | Botulinum a toxin treatment of hemifacial spasm and blepharospasm. |
title_short | Botulinum a toxin treatment of hemifacial spasm and blepharospasm. |
title_sort | botulinum a toxin treatment of hemifacial spasm and blepharospasm. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053713/ https://www.ncbi.nlm.nih.gov/pubmed/8305141 |
work_keys_str_mv | AT parkyc botulinumatoxintreatmentofhemifacialspasmandblepharospasm AT limjk botulinumatoxintreatmentofhemifacialspasmandblepharospasm AT leedk botulinumatoxintreatmentofhemifacialspasmandblepharospasm AT yisd botulinumatoxintreatmentofhemifacialspasmandblepharospasm |